FIELD: medicine.
SUBSTANCE: Pliss lymphosarcoma is transferred subcutaneously into male rats. One hours after the tumour transfer, Cytochrome C is administered intraperitoneally according to the therapeutic schedule in a daily dose of 1.6 mg/kg intermittently; the preparation is administered for 5 days daily with an interval of 2 days. The treatment length is 10 weeks.
EFFECT: regression of the tumours or prevented tumour growth.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR INHIBITING TUMOR GROWTH AND METHOD FOR INHIBITING TUMOR GROWTH IN EXPERIMENT | 2006 |
|
RU2320334C1 |
| METHOD FOR PREVENTION OF PULMONARY METASTATIC LESIONS EXPERIMENTALLY | 2013 |
|
RU2546034C1 |
| METHOD FOR CORRECTION OF CANCER CARRIER LIVER MORPHOLOGICAL STATE | 2004 |
|
RU2271813C1 |
| METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY | 2014 |
|
RU2561294C1 |
| METHOD OF INCREASE OF ANTITUMORAL EFFECT OF CHEMOTHERAPY | 2007 |
|
RU2361590C2 |
| AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
| AGENT FOR NORMALIZING OF CD4 T-LYMPHOCYTE LEVEL IN PLISS LYMPHOSARCOMA | 2006 |
|
RU2316338C1 |
| METHOD FOR PREVENTION OF CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410093C1 |
| AGENT FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION AND METHOD FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION | 2006 |
|
RU2319486C1 |
| MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
